LOTREXON

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LOTREXON was filed as Word mark on 07/07/2020 at the World Intellectual Property Organization.

Trademark Details Last update: April 25, 2023

Trademark form Word mark
File reference 1548002
Countries Canada China European Community United Kingdom India Russia
Base trademark US No. 90039089, July 7, 2020
Application date July 7, 2020
Expiration date August 15, 2022

Trademark owner

3001 Aloma Ave
Winter Park FL 32792
US

Trademark representatives

P.O. Box 3308 West Chester PA 19381 US

goods and services

05 Pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on the nervous system; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have immunomodulatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have anti-inflammatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have hematopoietic lineage differentiation activity; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on various G protein-coupled receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on non-GPCRs, including Toll-like receptors and p receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, for the prevention and treatment of gastrointestinal, neurological, immunological, oncological and/or viral diseases and disorders

Trademark history

Date Document number Area Entry
March 30, 2023 2023/17 Gaz US RAW: Total Ceasing Effect
October 4, 2022 2022/41 Gaz CA Rejection
December 21, 2021 2022/1 Gaz CA Rejection
August 17, 2021 2021/46 Gaz BR RAW: Second Part Fee Not Paid
August 17, 2021 2021/33 Gaz BR Rejection
April 19, 2021 2021/17 Gaz IN Rejection
January 20, 2021 2021/3 Gaz EM Rejection
January 11, 2021 2021/2 Gaz CN Rejection
December 9, 2020 2020/50 Gaz GB Rejection
December 2, 2020 2020/50 Gaz RU Rejection
September 15, 2020 2020/38 Gaz IN Rejection
July 7, 2020 2020/34 Gaz US Registration

ID: 141548002